透過您的圖書館登入
IP:3.138.114.94
  • 期刊

Attenuation of High Glucose-Induced Rat Cardiomyocyte Apoptosis by Exendin-4 via Intervention of HO-1/Nrf-2 and the PI3K/AKT Signaling Pathway

本篇文章尚未正式出版,請點選「加入追蹤」跟進後續出版資訊!

摘要


Exendin-4, a glucagon-like peptide-1 receptor agonist, demonstrated cytoprotective actions beyond glycemic control in recent studies. The aims of the present study were to investigate the effects of exendin-4 on high glucose (HG)-induced cardiomyocyte apoptosis and the possible mechanisms. Rat cardiomyocytes were divided into 3 groups: normal glucose group (NG group), HG group and HG +exendin-4 group (HG+Ex Group). Cardiomyocyte apoptosis was evaluated by double-staining with annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) and flow cytometry. Intracellular reactive oxygen species (ROS) production was detected by 2', 7'-dichlorodihydrofluorescein diacetate (DCHF-DA) incubation and fluorescence microscopy. LY294002 (LY), a phosphoinositide 3-kinase (PI3K) pathway inhibitor, was added to the medium of the HG+Ex+LY Group for further western blot analysis. The proteins analyzed involved oxidative stress-associated proteins, heme oxygenase-1 (HO-1) and nuclear factor E2-related factor 2 (Nrf-2), and apoptosis-associated proteins, caspase-3, Bax/B-cell lymphoma 2 (Bcl-2) and p-AKT/AKT. HG treatment induced cardiomyocyte apoptosis (P = 0.00) and clearly upregulated ROS production (P = 0.00); exendin-4 co-incubation also ameliorated cardiomyocyte apoptosis (P = 0.004) and decreased ROS (P = 0.00) level significantly. HO-1 and Nrf-2 protein expression levels decreased significantly in the HG group (P < 0.05), but the levels were elevated by exendin-4 intervention (P < 0.05). Furthermore, exendin-4 attenuated HG-induced higher protein expression, including cleaved caspase-3 and Bax, increased the expression of Bcl-2 protein (P < 0.05). However, these impacts of exendin-4 were counteracted significantly by co-incubation with LY294002. In addition, exendin-4 ameliorated HG-induced p-AKT/AKT lower expression, and this impact was also suppressed by LY294002. Exendin-4 ameliorates HG-induced cardiomyocyte apoptosis, and the mechanisms may involve anti-oxidative stress via the HO-1/Nrf-2 system, as well as intervention of the PI3K/AKT signaling pathway.

參考文獻


Anagnostis, P.,Athyros, V.G.,Adamidou, F.,Panagiotou, A.,Kita, M.,Karagiannis, A.,Mikhailidis, D.P.(2011).Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.Diabetes Obes. Metab..13,302-312.
Baggio, L.L.,Drucker, D.J.(2007).Biology of incretins: GLP-1 and GIP.Gastroenterology.132,2131-2157.
Chang, G.,Zhang, D.,Yu, H.,Zhang, P.,Wang, Y.,Zheng, A.,Qin, S.(2013).Cardioprotective effects of exenatide against oxidative stress-induced injury.Int. J. Mol. Med..32,1011-1020.
Drucker, D.J.,Nauck, M.A.(2006).The incretin system: glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.Lancet.368,1696-1705.
Harkavyi, A.,Whitton, P.S.(2010).Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.Brit. J. Pharmacol..159,495-501.

延伸閱讀